A CD4+ count below 200 cells/μL, advanced age at antiretroviral therapy initiation, and protease inhibitor use were associated with low-level viremia and increased risk for virologic failure among ...

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir ...

Reviewed by Carrie D. Johnston, MD, MS, Assistant Professor in the Division of Infectious Diseases at Weill Cornell Medical College in New York City. "Medical Journeys" is a set of clinical resources ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...

Without ART, people living with HIV can have a viral load of 30,000 to more than 500,000 copies/mL, depending on the stage of infection. While using lab-based plasma sample methods provides the most ...

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In ...

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

Medical advancements over the last several decades have made great strides in the treatment of HIV. Pharmaceutical treatments are able to contain and reduce a patient's viral load to the point where ...

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive ...